FI941758A0 - Rekombitooppipeptidejä - Google Patents

Rekombitooppipeptidejä

Info

Publication number
FI941758A0
FI941758A0 FI941758A FI941758A FI941758A0 FI 941758 A0 FI941758 A0 FI 941758A0 FI 941758 A FI941758 A FI 941758A FI 941758 A FI941758 A FI 941758A FI 941758 A0 FI941758 A0 FI 941758A0
Authority
FI
Finland
Prior art keywords
protein
peptides
recombitope
recombitope peptides
cell
Prior art date
Application number
FI941758A
Other languages
English (en)
Swedish (sv)
Other versions
FI109809B (fi
FI941758A (fi
Inventor
Bruce L Rogers
Jay P Morgenstern
Julian F Bond
Richard D Garman
Mei-Chang Kuo
Malcolm Morville
Original Assignee
Immunologic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/807,529 external-priority patent/US5547669A/en
Application filed by Immunologic Pharma Corp filed Critical Immunologic Pharma Corp
Publication of FI941758A0 publication Critical patent/FI941758A0/fi
Publication of FI941758A publication Critical patent/FI941758A/fi
Application granted granted Critical
Publication of FI109809B publication Critical patent/FI109809B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
FI941758A 1991-10-16 1994-04-15 Menetelmä uusien peptidien valmistamiseksi FI109809B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US77785991A 1991-10-16 1991-10-16
US77785991 1991-10-16
US80752991 1991-12-13
US07/807,529 US5547669A (en) 1989-11-03 1991-12-13 Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
US9208694 1992-10-16
PCT/US1992/008694 WO1993008280A1 (en) 1991-10-16 1992-10-16 Recombitope peptides

Publications (3)

Publication Number Publication Date
FI941758A0 true FI941758A0 (fi) 1994-04-15
FI941758A FI941758A (fi) 1994-06-16
FI109809B FI109809B (fi) 2002-10-15

Family

ID=27119373

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941758A FI109809B (fi) 1991-10-16 1994-04-15 Menetelmä uusien peptidien valmistamiseksi

Country Status (15)

Country Link
EP (1) EP0610335B1 (fi)
JP (1) JP4246794B2 (fi)
KR (1) KR100271417B1 (fi)
AT (1) ATE382699T1 (fi)
AU (1) AU682658B2 (fi)
CA (1) CA2121498C (fi)
DK (1) DK0610335T3 (fi)
ES (1) ES2300100T3 (fi)
FI (1) FI109809B (fi)
HU (1) HU227959B1 (fi)
IL (1) IL103456A (fi)
NO (1) NO316073B1 (fi)
NZ (2) NZ244782A (fi)
PT (1) PT100978B (fi)
WO (1) WO1993008280A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6120769A (en) * 1989-11-03 2000-09-19 Immulogic Pharmaceutical Corporation Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
US6019972A (en) * 1989-11-03 2000-02-01 Immulogic Pharmaceutical Corporation Peptides of human T cell reactive feline protein (TRFP)
IL105153A (en) * 1992-03-25 1999-12-22 Immulogic Pharma Corp Therapeutic compositions comprising peptides derived from human t cell reactive feline protein
US6759234B1 (en) * 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
KR100487456B1 (ko) * 1996-03-10 2005-11-25 메이지 데어리즈 코포레이션 알레르기질환에대한펩티드면역치료제
ATE412175T1 (de) * 1996-03-21 2008-11-15 Circassia Ltd Verwendung von kryptischen peptiden zur induktion von immunologischer toleranz
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
JP3945822B2 (ja) * 1996-05-24 2007-07-18 カイロン コーポレイション 複数エピトープ融合タンパク質
JP4176750B2 (ja) * 1996-06-14 2008-11-05 明治乳業株式会社 Ｔ細胞エピトープペプチド
US7112329B1 (en) 1996-06-14 2006-09-26 Meiji Milk Products Co. Ltd. T cell epitope peptide
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
AUPQ776100A0 (en) 2000-05-26 2000-06-15 Australian National University, The Synthetic molecules and uses therefor
EP1221317A1 (en) 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
EP1440979B1 (en) * 2003-01-21 2005-10-19 BIOMAY Produktions- und Handels- Aktiengesellschaft Process for the preparation of hypoallergenic mosaic proteins
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
GB2455108A (en) * 2007-11-28 2009-06-03 Circassia Ltd T-Cell dependent method for detecting non-allergic or intrinsic disorders
AU2014369866A1 (en) 2013-12-23 2016-06-30 Alk-Abello A/S Peptide combinations and uses thereof in treating dust mite allergy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2013359A6 (es) * 1988-11-04 1990-05-01 Corporacion Biolog Farmaceutic Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.
EP0500785B1 (en) * 1989-11-03 2002-04-17 Immulogic Pharmaceutical Corporation A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor
EP0548200B1 (en) * 1990-09-11 1999-04-14 Institute For Child Health Research Cloning and sequencing of allergens of dermatophagoides (house dust mite)

Also Published As

Publication number Publication date
HUT70263A (en) 1995-09-28
AU682658B2 (en) 1997-10-16
ES2300100T3 (es) 2008-06-01
JPH07503362A (ja) 1995-04-13
ATE382699T1 (de) 2008-01-15
HU227959B1 (en) 2012-07-30
NO316073B1 (no) 2003-12-08
NO941370D0 (no) 1994-04-15
EP0610335B1 (en) 2008-01-02
DK0610335T3 (da) 2008-04-28
KR100271417B1 (ko) 2000-12-01
FI109809B (fi) 2002-10-15
CA2121498A1 (en) 1993-04-29
HU9401109D0 (en) 1994-07-28
NZ299122A (en) 2005-02-25
PT100978B (pt) 1999-10-29
EP0610335A1 (en) 1994-08-17
IL103456A (en) 2006-06-11
PT100978A (pt) 1994-01-31
IL103456A0 (en) 1993-03-15
FI941758A (fi) 1994-06-16
NZ244782A (en) 1996-12-20
AU2794092A (en) 1993-05-21
NO941370L (no) 1994-06-08
WO1993008280A1 (en) 1993-04-29
JP4246794B2 (ja) 2009-04-02
CA2121498C (en) 2009-02-17

Similar Documents

Publication Publication Date Title
FI941758A (fi) Rekombitooppipeptidejä
TR199801722T2 (xx) Peptit imm�nojenler.
DE3751553T2 (de) Immunomodulare mittel und deren verwendung.
DE68925226T2 (de) Monoklonale Antikörper
BR9106303A (pt) Imonogeno humano composicao,celula de mamifero,peptido,vacina contra sintomas de esclerose multipla,metodo para tratar ou prevenir doenca com sintomas de esclerose multipla e conjunto para diagnosticar esclerose multipla
EP0584715A3 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper.
ATE244299T1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
NO950526D0 (no) T-celleepitoper av raigresspollen-allergen
DE3855280T2 (de) Von mca 16-88 erkanntes antigen
FI924576A (fi) Ctaa 28a32, antigen identiefierad av mca 28a32

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: HESKA CORPORATION

Free format text: HESKA CORPORATION

PC Transfer of assignment of patent

Owner name: MERCK PATENT GMBH

Free format text: MERCK PATENT GMBH

MA Patent expired